CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Vexim SA is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Vexim SA
75, rue Saint Jean
Phone: +33 561488663p:+33 561488663 Balma, 31130  France Ticker: ALVXMALVXM

This company was Merged or Acquired on 10/24/2017.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
Vexim SA is a France-based company engaged in the medical sector. It develops invasive medical instruments used in preventing and treating vertebral fractures. The Company markets its flagship product, SpineJack, in Germany, the United Kingdom, Austria and Ireland under a agreement with Stryker Corp, in France via its own sales force and further distributers in Spain, Portugal, Italy, Turkey, Argentina and South Africa. SpineJack is a titanium implant which is inserted into the patient's vertebra via a transpedicular, minimally invasive approach. Furthermore, the Company's product portfolio includes Cohesion, a PolyMethyl MethAcrylat (PMMA) bone cement and a three-dimensional (3D) mapping software for combining images from Computerized Tomography (CT) scans into a 3D model. The Company operates through VEXIM and a technological system in the injection of orthopedic cement for its development in vertebroplasty. The Company is a subsidiary of Stryker Corporation.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/201712/31/2016Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board SteveSwinson
Chief Executive Officer VincentGardes 12/2/2011 12/2/2011
Deputy Chief Executive Officer JeromeMarzinski 10/1/2013 10/1/2013
10 additional Officers and Directors records available in full report.

General Information
Number of Employees: 44 (As of 12/31/2016)
Outstanding Shares: 7,638,348 (As of 6/30/2017)
Stock Exchange: EPA
Fax Number: +33 561489519
Email Address: vexim@vexim.fr


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023